Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders
Sheraz Khoja, Nhat Huynh, Alicia M. P. Warnecke, et al.
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1697-1709
Open Access | Times Cited: 22

Showing 22 citing articles:

Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee, Ariane Sternberg, Ulrike Stange, et al.
Pharmacological Research (2020) Vol. 157, pp. 104859-104859
Open Access | Times Cited: 577
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects
Gaber El‐Saber Batiha, Ali Alqahtani, Omotayo B. Ilesanmi, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 8, pp. 196-196
Open Access | Times Cited: 159
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 5
Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders
Jennifer K. Melbourne, Keith Thompson, Hui Peng, et al.
Progress in molecular biology and translational science (2019), pp. 179-221
Closed Access | Times Cited: 40
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function
Hillary A. Wadsworth, Alicia M. P. Warnecke, Joshua C. Barlow, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Resolving the Ionotropic P2X4 Receptor Mystery Points towards a New Therapeutic Target for Cardiovascular Diseases
Bruno Bragança, Paulo Correia‐de‐Sá
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5005-5005
Open Access | Times Cited: 17
Agonists, Antagonists, and Modulators of P2X7 Receptors
Christa E. Müller, Vigneshwaran Namasivayam
Methods in molecular biology (2022), pp. 31-52
Closed Access | Times Cited: 10
Synthesis and evaluation of avermectin–imidazo[1,2-a]pyridine hybrids as potent GABAA receptor modulators
Yulia A. Volkova, Irina V. Rassokhina, Eugeny A. Kondrakhin, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105904-105904
Closed Access | Times Cited: 9
A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice
Joshua Silva, Eileen Carry, Xue Chen, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1791-1791
Open Access | Times Cited: 10
A novel pharmacotherapy approach using P-glycoprotein (PGP/ABCB1) efflux inhibitor combined with ivermectin to reduce alcohol drinking and preference in mice
Joshua Silva, Sheraz Khoja, Liana Asatryan, et al.
Alcohol (2020) Vol. 86, pp. 1-8
Open Access | Times Cited: 9
Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression
Bruk Getachew, Yousef Tizabi
Behavioural Brain Research (2019) Vol. 376, pp. 112220-112220
Open Access | Times Cited: 7
Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior.
Bruk Getachew, Rachel E. Reyes, Daryl L. Davies, et al.
PubMed (2019) Vol. 3, Iss. 1, pp. 134-142
Closed Access | Times Cited: 5
PRODUCTION OF AVERMECTINS: BIOTECHNOLOGIES AND ORGANIC SYNTHESIS
М. Х. Джафаров, Ф. И. Василевич, Mikail N. Mirzaev
Sel skokhozyaistvennaya Biologiya (2019) Vol. 54, Iss. 2, pp. 199-215
Open Access | Times Cited: 4
ПОЛУЧЕНИЕ АВЕРМЕКТИНОВ: БИОТЕХНОЛОГИИ И ОРГАНИЧЕСКИЙ СИНТЕЗ
М. Х. Джафаров, Ф. И. Василевич, Mikail N. Mirzaev
Sel skokhozyaistvennaya Biologiya (2019) Vol. 54, Iss. 2, pp. 199-215
Open Access | Times Cited: 4
The macrocyclic lactones ivermectin and moxidectin show differential effects on rotational behavior in the 6-hydroxydopamine mouse model of Parkinson’s disease
Alicia M. P. Warnecke, Moon Sung Kang, Michael W. Jakowec, et al.
Behavioural Brain Research (2020) Vol. 393, pp. 112804-112804
Open Access | Times Cited: 3
In Silico Analysis of FDA Drugs as P2X4 Modulators for the Treatment of Alcohol Use Disorder
Francisco Reyes‐Espinosa, María G. Nieto‐Pescador, Virgilio Bocanegra‐García, et al.
Molecular Informatics (2020) Vol. 39, Iss. 9
Closed Access | Times Cited: 2
Forging Ahead the Repositioning of Multitargeted Drug Ivermectin
Srividya Atmakuri, Shweta Nene, Dharmendra Kumar Khatri, et al.
Current Drug Delivery (2022) Vol. 20, Iss. 8, pp. 1049-1066
Closed Access | Times Cited: 1
Aspectos toxicológicos da ivermectina: um estudo dos efeitos na morfologia do fígado de ratas prenhes
Juliana Pinto de Medeiros, Rodrigo Reges dos Santos Silva, Leandro Paes de Brito, et al.
Research Society and Development (2021) Vol. 10, Iss. 1, pp. e25410111693-e25410111693
Open Access | Times Cited: 1
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function
Hillary A. Wadsworth, Alicia M. P. Warnecke, Joshua C. Barlow, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
<b>Efeitos da exposição à ivermectina em ratos e coelhos:</b> aspectos reprodutivos
Natália Boneti Moreira
(2019)
Open Access
Investigation of the impact of antiparasitic drug moxidectin on the rewarding effects of alcohol
Abdurrahman Ekici, Esra Gürbüz, Mehmet Berköz, et al.
General Physiology and Biophysics (2022) Vol. 41, Iss. 03, pp. 245-253
Open Access
Page 1

Scroll to top